List of insiders holdings for LadRx Corp:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| KRIEGSMAN STEVEN A Chief Executive Officer | 2020-08-13 18:43:12 | 3,668,038 0 | 3,668,038 | Form 4 |
| Patterson Scott Bradford 10% Owner | 2016-12-27 14:25:54 | 3,160,653 0 | 3,160,653 | Form 13G |
| Brien Earl W Director | 2020-08-20 06:10:24 | 890,247 0 | 890,247 | Form 4 |
| IGNARRO LOUIS Director | 2020-08-13 18:41:59 | 600,785 0 | 600,785 | Form 4 |
| LEVITT DANIEL J EVP and Chief Medical Officer | 2016-12-19 14:32:19 | 400,000 0 | 400,000 | Form 4 |
| Barber Jack R Chief Scientific Officer | 2009-07-06 15:28:42 | 400,000 0 | 400,000 | Form 4 |
| CAPPELLO ALEXANDER L Director | 2003-10-17 20:01:51 | 374,747 0 | 374,747 | Form 4 |
| Ware Olivia C Chief Commercial Officer | 2016-01-14 18:28:41 | 350,000 0 | 350,000 | Form 4 |
| Levin Ben SVP-Legal Affairs/GC/Secy | 2015-12-17 12:56:32 | 300,000 0 | 300,000 | Form 4 |
| PEACOCK KIRK Chief Financial Officer | 2003-08-27 14:45:15 | 210,000 0 | 210,000 | Form 3 |
| Geyer David Scott Sr. V.P. of Manufacturing | 2011-12-13 19:32:33 | 200,000 0 | 200,000 | Form 4 |
| LINK MAX Director | 2013-12-12 16:57:42 | 180,000 0 | 180,000 | Form 4 |
| SELTER MARVIN R Director | 2013-12-12 17:52:10 | 180,000 0 | 180,000 | Form 4 |
| Wennekamp Richard L. Director | 2014-12-16 17:35:17 | 180,000 0 | 180,000 | Form 4 |
| Cohen Cheryl Director | 2015-12-17 12:53:01 | 180,000 0 | 180,000 | Form 4 |
| SELTER ERIC JAY Director | 2015-12-17 13:00:02 | 180,000 0 | 180,000 | Form 4 |
| Chawla Anita J Director | 2016-12-19 12:35:11 | 180,000 0 | 180,000 | Form 4 |
| RUBINFELD JOSEPH Director | 2016-12-19 12:59:57 | 180,000 0 | 180,000 | Form 4 |
| LIBERMAN GREGORY R General Cnsel & Corp Secretay | 2004-01-14 13:13:32 | 175,000 0 | 175,000 | Form 3 |
| Tepper Mark Vice President | 2007-05-10 12:55:27 | 175,000 0 | 175,000 | Form 4 |
| SHAH JAISIM Sr. VP - Business Development | 2009-05-05 15:43:17 | 150,000 0 | 150,000 | Form 3 |
| Wieland Douglas Scott Sr VP - Drug Development | 2016-12-19 14:27:02 | 150,000 0 | 150,000 | Form 4 |
| Chawla Shanta M.D. Senior VP-Drug Development | 2017-06-20 18:33:01 | 122,100 0 | 122,100 | Form 3 |
| FOGELMAN MITCHELL K Chief Financial Officer | 2008-11-24 20:37:46 | 100,000 0 | 100,000 | Form 4 |
| Ng Shi Chung Sr VP Research & Development | 2008-11-24 20:02:12 | 50,000 0 | 50,000 | Form 4 |
| Natalizio Matt Chief Financial Officer | 2006-06-21 17:23:21 | 50,000 0 | 50,000 | Form 4 |
| Kratz Felix Vice President Drug Discovery | 2018-01-02 17:27:24 | 25,000 0 | 25,000 | Form 4 |
| Snowdy Stephen Chief Executive Officer | 2024-01-29 16:05:14 | 25,000 0 | 25,000 | Form 4 |
| CARNAHAN RAYMOND C JR Director until 10-10-2003 Director | 2003-10-17 17:53:11 | 20,000 0 | 20,000 | Form 4/A |
| MCDADE HERBERT H JR Director until 10-10-2003 Director | 2003-10-17 18:16:22 | 20,000 0 | 20,000 | Form 4 |
| CALOZ JOHN Y Chief Financial Officer | 2024-01-29 16:05:19 | 15,000 0 | 15,000 | Form 4 |
| Simpson Jennifer K. Director | 2024-01-29 16:05:23 | 5000 0 | 5000 | Form 4 |
| Claiborne Cary J Director | 2024-01-29 16:06:09 | 5000 0 | 5000 | Form 4 |
| Caldwell Joel K Director | 2024-01-29 16:06:16 | 5000 0 | 5000 | Form 4 |
| Curtis Eric Pres., Chief Operating Officer | 2018-05-21 16:25:49 | 0 0 | 0 | Form 3 |